JP2010513228A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513228A5
JP2010513228A5 JP2009538452A JP2009538452A JP2010513228A5 JP 2010513228 A5 JP2010513228 A5 JP 2010513228A5 JP 2009538452 A JP2009538452 A JP 2009538452A JP 2009538452 A JP2009538452 A JP 2009538452A JP 2010513228 A5 JP2010513228 A5 JP 2010513228A5
Authority
JP
Japan
Prior art keywords
antigen
monoclonal antibody
variable region
cell line
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009538452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513228A (ja
Filing date
Publication date
Priority claimed from US11/562,747 external-priority patent/US20100047252A1/en
Application filed filed Critical
Publication of JP2010513228A publication Critical patent/JP2010513228A/ja
Publication of JP2010513228A5 publication Critical patent/JP2010513228A5/ja
Withdrawn legal-status Critical Current

Links

JP2009538452A 2006-11-22 2007-11-15 プロテインa選択性を有する抗体 Withdrawn JP2010513228A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/562,747 US20100047252A1 (en) 2006-11-22 2006-11-22 Antibody with protein a selectivity
PCT/US2007/084739 WO2008143697A2 (en) 2006-11-22 2007-11-15 Antibody with protein a selectivity

Publications (2)

Publication Number Publication Date
JP2010513228A JP2010513228A (ja) 2010-04-30
JP2010513228A5 true JP2010513228A5 (enExample) 2011-01-13

Family

ID=39811884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538452A Withdrawn JP2010513228A (ja) 2006-11-22 2007-11-15 プロテインa選択性を有する抗体

Country Status (4)

Country Link
US (1) US20100047252A1 (enExample)
EP (1) EP2084186A2 (enExample)
JP (1) JP2010513228A (enExample)
WO (1) WO2008143697A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136861A2 (en) * 2006-11-22 2008-11-13 3M Innovative Properties Company Inactivated and dried biological preparations
US20100099115A1 (en) 2006-11-22 2010-04-22 Mach Patrick A Systems and methods for preparing and analyzing samples
CN101663581A (zh) * 2007-04-19 2010-03-03 3M创新有限公司 水分散性二氧化硅纳米颗粒在连接生物分子方面的用途
WO2008131063A1 (en) * 2007-04-19 2008-10-30 3M Innovative Properties Company Methods of use of solid support material for binding biomolecules
EP2220500A4 (en) * 2007-11-20 2010-12-15 3M Innovative Properties Co METHOD FOR ANALYZING A BACTERIUM SAMPLE USING A POLYMER DETECTOR CONTAINING DIACETYLENE
JP2011516824A (ja) * 2008-02-20 2011-05-26 スリーエム イノベイティブ プロパティズ カンパニー 全細胞捕捉及びatp分析を用いた細菌試料の分析方法
EP3281947B1 (en) 2009-04-03 2020-02-12 The University of Chicago Compositions and methods related to protein a (spa) variants
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
US9556281B2 (en) 2011-08-15 2017-01-31 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein A
EP2793944B1 (en) 2011-12-23 2025-10-08 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
US10738121B2 (en) 2015-02-27 2020-08-11 The General Hospital Corporation Therapeutic use of integrin-binding antibodies
AU2020273471B2 (en) 2019-05-14 2026-05-07 The University Of Chicago Methods and compositions comprising Staphylococcus protein A (SpA) variants
US12528882B2 (en) 2019-09-13 2026-01-20 The University Of Chicago Methods and compositions for treating staphylococcal infections
CN118580347B (zh) * 2024-05-13 2025-02-07 重庆原伦生物科技有限公司 一种抗金黄色葡萄球菌蛋白a的单克隆抗体及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6994855B1 (en) * 1994-08-22 2006-02-07 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US6008341A (en) * 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US5594116A (en) * 1995-11-08 1997-01-14 Promega Corporation Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay
FR2746398B1 (fr) * 1996-03-21 1998-04-30 Bio Merieux Anticorps specifique de staphylococcus aureaus, et utilisations
WO2002102829A2 (en) * 2001-06-15 2002-12-27 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
PL374311A1 (en) * 2001-12-21 2005-10-03 Immunex Corporation Methods for purifying protein
AU2003284643A1 (en) * 2002-11-22 2004-06-18 Daiichi Pure Chemicals Co., Ltd. Method of examining staphylococcus aureus
WO2008064232A2 (en) * 2006-11-22 2008-05-29 3M Innovative Properties Company Fluidic antibody-containing devices and methods

Similar Documents

Publication Publication Date Title
JP2010509937A5 (enExample)
HRP20201634T1 (hr) Monoklonsko protutijelo protiv interleukina-31
JP2013198490A5 (enExample)
NZ595464A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
PE20110801A1 (es) Anticuerpos con reactividad cruzada y biespecificos anti-il-17a/f
CA2953714C (en) Anti-tnfa antibodies with ph-dependent antigen binding
WO2013037484A8 (en) ANTI-αβTCR ANTIBODY
EA201190132A1 (ru) Гуманизированные антитела, связывающиеся с cd19, и их применение
RU2012147638A (ru) Антитела против растворимого st-2 человека и способы анализа
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
NZ591541A (en) Pcsk9 antagonists
ES2572231T3 (es) Anticuerpos monoclonales anti-IL-21 humana
NO20074867L (no) Antistoffer mot CCR5 og anvendelser derav
NZ598202A (en) High affinity human antibodies to human angiopoietin-2
NZ587198A (en) Monoclonal antibodies against the rgm a protein and uses thereof
HRP20140266T1 (hr) Postupci inhibiranja vezanja endosijalina na ligande
BRPI0821682A2 (pt) Anticorpo monoclonal ou uma sua porção ligante de antígeno, composição farmacêutica, métodos para tratar uma doença imunológica e para produzir o anticorpo monoclonal ou sua porção ligante de antígeno, linhagem de célula isolada, molécula de ácido nucleico isolada, vetor, célula hospedeira, e, processo para identificar anticorpos anti-mif.
WO2008143697A3 (en) Antibody with protein a selectivity
MX2009008608A (es) Anticuerpos monoclonales anti-cxcl13.
WO2008140570A3 (en) Antibody with protein a selectivity
RU2018102606A (ru) Молекулы, связывающиеся с psl pseudomonas, и пути их применения
EA201990673A1 (ru) Антитела, специфически связывающиеся с il-17a, и их функциональные фрагменты
JP2018507254A5 (enExample)
JP2017518260A5 (enExample)
RU2016107814A (ru) Новое антитело к tslp-рецептору человека